Trial Identifier: | D8450C00005 |
Sponsor: | AstraZeneca |
NCTID:: | NCT06194825 |
Start Date: | December 2023 |
Primary Completion Date: | March 2025 |
Study Completion Date: | March 2027 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
CN | Beijing, CN, 100037 |
CN | Beijing, CN, 100730 |
CN | Beijing, CN, 100191 |
CN | Beijing, CN, 100034 |
CN | Beijing, CN, 100029 |
CN | Changsha, CN, 410013 |
CN | Changsha, CN, 430033 |
CN | Changsha, CN, 410008 |
CN | Chengdu, CN, 610072 |
CN | Chengdu, CN, 610041 |
CN | Chongqing, CN, 400010 |
CN | Chongqing, CN, 400042 |
CN | Dalian, CN, 116011 |
CN | guangzhou, CN, 510062 |
CN | Guangzhou, CN, 510100 |
CN | Ha'er bin, CN, 150001 |
CN | hangzhou, CN, 310052 |
CN | Hangzhou, CN, 310003 |
CN | Hangzhou, CN, 310014 |
CN | Jinan, CN, 250001 |
CN | Nanchang, CN, 330006 |
CN | Nanjing, CN, 210006 |
CN | Shanghai, CN, 200032 |
CN | Shanghai, CN, 200025 |
CN | Shenyang, CN, 110004 |
CN | Shijiazhuang, CN, 050000 |
CN | suzhou, CN, 215006 |
CN | Taiyuan, CN, 030001 |
CN | Wenzhou, CN, CN-325000 |
CN | Wuhan, CN, 430060 |
CN | Wuhan, CN, 430030 |
CN | Xi'an, CN, 710061 |